查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684680

携带式血红素分析仪市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Portable Hemoglobin Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球便携式血红素分析仪市值为 3.597 亿美元，预计在 2025 年至 2034 年期间以 5% 的复合年增长率稳步增长。对可获取、快速和准确的诊断解决方案的需求不断增长，凸显了便携式血红蛋白分析仪在现代医疗保健中日益增长的重要性。随着人们对医疗保健问题的认识不断提高，即时检测设备的采用也在不断增加，这些设备可以增强医疗保健提供者的能力并改善患者的治疗效果。这些分析仪为满足城市和偏远地区人口的诊断需求提供了重要工具，弥补了全球医疗保健基础设施的关键空白。

便携式血红素分析仪市场 - IMG1

贫血仍然是全球普遍的健康挑战，影响着数十亿人，特别是妇女、儿童和老年人。便携式血红素分析仪提供了重要的解决方案，可提供快速可靠的结果，支持早期诊断和及时介入。该设备的便携性和易用性使其成为无法使用传统实验室设施的医疗服务不足和偏远地区的必备设备。世界各国政府和医疗保健组织日益提倡早期发现和有效管理贫血，特别是在医疗基础设施不足的地区。对增强诊断能力的推动极大地增强了对便携式血红蛋白分析仪的需求，有助于改善医疗保健的机会和公平性。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 3.597 亿美元
预测值 5848亿美元
复合年增长率 5％

市场分为两种主要产品类型：手持式分析仪和桌上型分析仪。 2024年，手持式分析仪创造了2.027亿美元的收入，巩固了其作为领先领域的地位。它们设计紧凑、价格实惠且具有用户友好功能，特别适合乡村诊所、急诊室和家庭医疗保健环境等即时护理场所。手持式分析仪提供的快速、精确的结果对于医疗保健提供者管理贫血和其他相关疾病至关重要，凸显了它们在现代诊断中的关键作用。

携带式血红素分析仪的应用包括贫血诊断、慢性病监测和其他用途。贫血诊断领域预计将达到最高成长，复合年增长率为 5.2%，到 2034 年将达到 3.4 亿美元。便携式血红素分析仪在促进早期检测和管理方面发挥着变革性的作用，这对于改善健康结果至关重要。它们的重要性遍及已开发地区和发展中地区，贫血在这些地区仍然是一个重大的公共卫生问题，凸显了这些设备的全球相关性。

在美国，便携式血红素分析仪市场在 2024 年的价值为 1.338 亿美元，预计到 2034 年将以 4.4% 的复合年增长率增长。贫血的流行，特别是在妇女、儿童和老年人中，持续推动对可靠诊断解决方案的需求。便携式血红素分析仪可以满足这一需求，提供快速有效的结果，实现及时的医疗干预，并为全国各地的患者提供更好的健康结果。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 贫血和其他血液疾病盛行率上升
      • 即时诊断检测的需求不断增加
      • 便携式医疗设备和技术的进步
      • 越来越重视早期诊断和预防保健
    • 产业陷阱与挑战
      • 偏远和欠发达地区的可用性有限
      • 与便携式设备的准确性和可靠性相关的问题
  • 成长潜力分析
  • 2024 年定价分析
  • 监管格局
  • 技术格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按产品类型，2021 年至 2034 年

  • 主要趋势
  • 手持式分析仪
  • 桌上型分析仪

第六章：市场估计与预测：按技术，2021 – 2034 年

  • 主要趋势
  • 光度分析
  • 基于色谱法
  • 电化学检测
  • 其他技术

第 7 章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 贫血诊断
  • 慢性疾病监测
  • 其他应用

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 诊断实验室
  • 其他最终用户

第 9 章：市场估计与预测：按配销通路，2021 年至 2034 年

  • 主要趋势
  • 实体店面
  • 电子商务

第 10 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：公司简介

  • EKF
  • Abbott
  • ACON
  • Arkray
  • BeneCheck
  • BioHermes Bio & Medical Tech
  • boditech
  • cnoga
  • HemoCue
  • Horiba Medical
  • nova
  • SENSA CORE
  • SIEMENS Healthineers
  • Trinity Biotech
  • URIT
简介目录
Product Code: 13096

The Global Portable Hemoglobin Analyzers Market, valued at USD 359.7 million in 2024, is poised for steady growth at a CAGR of 5% from 2025 to 2034. This growth trajectory is driven by the escalating prevalence of anemia and other hemoglobin-related health conditions worldwide. The rising demand for accessible, rapid, and accurate diagnostic solutions underscores the increasing importance of portable hemoglobin analyzers in modern healthcare. As awareness of healthcare issues grows, so does the adoption of point-of-care testing devices that empower healthcare providers and enhance patient outcomes. These analyzers offer an essential tool for addressing the diagnostic needs of both urban and remote populations, bridging critical gaps in global healthcare infrastructure.

Portable Hemoglobin Analyzers Market - IMG1

Anemia continues to be a pervasive global health challenge, affecting billions of individuals, particularly women, children, and elderly populations. Portable hemoglobin analyzers provide a vital solution, delivering quick and reliable results that support early diagnosis and timely intervention. The devices' portability and ease of use make them indispensable in underserved and remote areas where access to traditional laboratory facilities is limited. Governments and healthcare organizations worldwide are increasingly advocating for early detection and effective management of anemia, particularly in regions with inadequate medical infrastructure. This push for enhanced diagnostic capabilities has significantly bolstered the demand for portable hemoglobin analyzers, contributing to improved healthcare access and equity.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$359.7 Million
Forecast Value$584.8 Billion
CAGR5%

The market is categorized into two primary product types: handheld analyzers and benchtop analyzers. In 2024, handheld analyzers generated USD 202.7 million in revenue, solidifying their position as the leading segment. Their compact design, affordability, and user-friendly features make them particularly suited for point-of-care settings such as rural clinics, emergency rooms, and home healthcare environments. The rapid and precise results provided by handheld analyzers are instrumental for healthcare providers managing anemia and other related conditions, underscoring their critical role in modern diagnostics.

Applications of portable hemoglobin analyzers span anemia diagnosis, chronic disease monitoring, and other uses. The anemia diagnosis segment is expected to achieve the highest growth, with a CAGR of 5.2%, and reach USD 340 million by 2034. This robust growth is fueled by the rising incidence of anemia across the globe, especially in vulnerable populations. Portable hemoglobin analyzers play a transformative role in facilitating early detection and management, which is crucial for improving health outcomes. Their importance extends across both developed and developing regions, where anemia persists as a significant public health issue, underscoring the global relevance of these devices.

In the United States, the portable hemoglobin analyzers market was valued at USD 133.8 million in 2024 and is anticipated to grow at a CAGR of 4.4% through 2034. The U.S. remains a pivotal market for these devices, supported by a robust healthcare system and an increasing emphasis on preventive care. The prevalence of anemia, particularly among women, children, and older adults, continues to drive the demand for reliable diagnostic solutions. Portable hemoglobin analyzers address this need by offering quick and efficient results, enabling timely medical interventions, and fostering better health outcomes for patients across the country.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of anemia and other blood disorders
      • 3.2.1.2 Increasing demand for point-of-care testing
      • 3.2.1.3 Advancements in portable medical devices and technology
      • 3.2.1.4 Growing focus on early diagnosis and preventive healthcare
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Limited availability in remote and underdeveloped areas
      • 3.2.2.2 Issues related to the accuracy and reliability of portable devices
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis, 2024
  • 3.5 Regulatory landscape
  • 3.6 Technology landscape
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld analyzers
  • 5.3 Benchtop analyzers

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Photometric analysis
  • 6.3 Chromatography-based
  • 6.4 Electrochemical detection
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Anemia diagnosis
  • 7.3 Chronic disease monitoring
  • 7.4 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospital
  • 8.3 Diagnostic laboratories
  • 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Brick and mortar
  • 9.3 E-commerce

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 EKF
  • 11.2 Abbott
  • 11.3 ACON
  • 11.4 Arkray
  • 11.5 BeneCheck
  • 11.6 BioHermes Bio & Medical Tech
  • 11.7 boditech
  • 11.8 cnoga
  • 11.9 HemoCue
  • 11.10 Horiba Medical
  • 11.11 nova
  • 11.12 SENSA CORE
  • 11.13 SIEMENS Healthineers
  • 11.14 Trinity Biotech
  • 11.15 URIT